BiotechTube
Home/Haisco Pharmaceutical Group/Wang Junmin
WJ

Wang Junmin

Founder, Chairman of the Board

Haisco Pharmaceutical Group

Therapeutic Areas

OncologyCardiovascularRespiratoryMetabolicCentral Nervous System

Haisco Pharmaceutical Group Pipeline

DrugIndicationPhase
HSK7653Type 2 DiabetesPhase III
HSK16149Neuropathic PainPhase III
HSK21542Pruritus (Chronic Liver Disease)Phase III
HSK401 (Bevacizumab Biosimilar)Non-small Cell Lung Cancer, Colorectal CancerPhase III
HSK31858Non-Cystic Fibrosis BronchiectasisPhase II
HSK29116B-cell MalignanciesPhase I/II

Leadership Team at Haisco Pharmaceutical Group

WJ
Wang Jun
General Manager / Director
View full Haisco Pharmaceutical Group profile